Christian Agbisit
Hematology & Oncology · Chesapeake, VANPI 1306376488
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.3% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations.
Across 94 payments — averaging $61.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$834
- Incyte Corporation$578
- Sanofi$548
- Beigene USA, Inc.$368
- Amgen$309
- Geron Corporation$282
- plus $3K from 34 others
What the payments were for
- Speaking & faculty fees$2003%
- Food & beverage$5,28691%
- Education$3025%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $834 |
| Incyte Corporation | 7 | $578 |
| Sanofi | 6 | $548 |
| Beigene USA, Inc. | 3 | $368 |
| Amgen | 3 | $309 |
| Geron Corporation | 3 | $282 |
| Daiichi Sankyo Inc. | 4 | $277 |
| AbbVie | 4 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $176 |
| ADC Therapeutics America, Inc. | 3 | $156 |
| Rigel Pharmaceuticals, Inc. | 2 | $151 |
| Jazz Pharmaceuticals Inc. | 1 | $143 |
| Pfizer | 3 | $142 |
| Teleflex LLC | 3 | $130 |
| E.r. Squibb & Sons, L.L.C. | 2 | $129 |
| Regeneron Healthcare Solutions, Inc. | 1 | $124 |
| Seagen Inc. | 1 | $124 |
| Johnson & Johnson | 4 | $121 |
| Sumitomo Pharma America, Inc. | 1 | $113 |
| Progenics Pharmaceuticals, Inc. | 1 | $98 |
| Taiho Oncology, Inc. | 3 | $82 |
| Servier Pharmaceuticals LLC | 3 | $71 |
| Beone Medicines USA, Inc. | 2 | $64 |
| Novartis | 2 | $62 |
| Legend Biotech USA Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| Caris MPI, Inc. | 2 | $39 |
| GSK | 2 | $39 |
| Tersera Therapeutics LLC | 1 | $29 |
| Exelixis Inc. | 1 | $26 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Sobi, Inc | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Nuvation Bio Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,788 in reported general payments places this provider in the 80th percentile of 293 hematology & oncology providers in Virginia.
Other hematology & oncology in Chesapeake
- Ruby KochharHampton$236K
- Victor YazbeckRichmond$190K
- David ChangNewport News$141K
- William ErshlerFairfax$139K
- Yue ZhangVirginia Beach$105K
- Jerome GoldschmidtChristiansburg$105K
- Attique SamdaniRichmond$104K
- Gary SimmonsNorfolk$82K
- Mark FlemingHampton$71K
- Sekwon JangFairfax$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.